Contralateral Claims Study of Clareon Vivity Pro (NCT07484191) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Contralateral Claims Study of Clareon Vivity Pro
231 participantsStarted 2026-04
Plain-language summary
The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
Who can participate
Age range22 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Key Inclusion Criteria:
* Cataracts in both eyes.
* Preoperative corneal astigmatism of less than 1.00 diopter (D) in each eye.
* Potential postoperative best corrected visual acuity (BCDVA) of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
* Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria:
* Desires monovision correction.
* Predicted post-operative residual astigmatism of more than 1D in either eye.
* Any ocular or systemic co-morbidity that, in the investigator's medical opinion, may confound the results of this study, prohibit the completion of the study assessments, or increase the risk for the subject.
* Other protocol-defined exclusion criteria may apply.
What they're measuring
1
Mean monocular photopic distance-corrected intermediate visual acuity (DCIVA)